Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong · Delayed Price · Currency is HKD 3.100
-0.690 (-18.21%)
Jul 10, 2026, 11:59 AM HKT
HKG:2563 Market Cap
HKG:2563 has a market cap or net worth of 1.38 billion as of July 9, 2026. Its market cap has decreased by -64.65% in one year.
Market Cap
1.38B
Enterprise Value
875.69M
Revenue
37.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.10
Market Cap Chart
Since October 31, 2024, HKG:2563's market cap has decreased from 7.58B to 1.38B, a decrease of -81.78%. That is a compound annual growth rate of -63.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.38B | -22.49% |
| Dec 31, 2025 | 1.78B | -75.18% |
| Dec 31, 2024 | 7.18B | -5.29% |
| Oct 31, 2024 | 7.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mabpharm | 1.65B |
| SinoMab BioScience | 1.59B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.59B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.55B |
| HighTide Therapeutics | 1.49B |
| Zhaoke Ophthalmology | 1.45B |
| CANbridge Pharmaceuticals | 1.17B |
| Cloudbreak Pharma | 1.01B |